“Reducing risk; prevention, early diagnosis and innovative treatments”.

Save the date:
6th – 7th of March 2020
at The Assembly Rooms, Edinburgh UK

Registration Suspended Pending Further Communication

The GOCF Mission statement

The Global Oral Cancer Forum is an international assembly of passionate professionals focussed on building awareness of gaps in prevention, patient care, technology and services across the oral cancer continuum by facilitating partnerships that transcend cultural and economic diversity.

The GOCF Vision Statement

By building these partnerships, The Forum will promote the changes required for a substantial impact on incidence, morbidity and mortality of oral cancer worldwide.

The GOCF’20 Forum Will Focus the Conversation On:


9 of every 10 cases of mouth cancer are preventable – how do we improve preventive strategies?

Risk Stratification

For the population, for the individual patient and for each tumour subtype.

Building Awareness

To get widespread engagement with our core messages and actionable outputs.

Early Diagnosis

The only proven intervention that improves survival yet, most cases present at late stage.


Has massive potential in cancer; what data sets do we need, in what format and owned by whom.

Get your ideas seen by the world’s oral cancer thought leaders

The organising committee of GOCF20 invites poster submissions of original work under the theme of “Reducing risk; prevention, early diagnosis and innovative treatments”. Get your work seen by thought leaders in the field of Oral Cancer from across the world at GOCF’20 in Edinburgh.

Organising Committee

Victor Lopes PhD, FRCS (Chair and Executive Director)

Trustee of the charity “Let’s Talk About Cancer” Edinburgh, U.K.

Niall McGoldrick BDS MFDS

Convenor of the charity “Let’s Talk About Cancer” / Specialty Registrar, Dental Public Health, NHS Fife, Scotland. U.K. 

A. Ross Kerr, DDS, MSD

Clinical Professor, New York University College of Dentistry, USA 

Saman Warnakulasuriya OBE, FDS, PhD, DSc

Emeritus Professor, Kings College London, UK 

Jatin Shah MD FACS

Elliott W Strong Chair in head and neck oncology
Memorial Sloan Kettering Cancer Center, USA 

Shannon Nanne RDH

Dental Hygienist, USA

Miriam Rosin PhD

British Columbia Oral Cancer Prevention Program
BC Cancer Agency

J. Silvio Gutkind PhD

Professor, Department of Pharmacology
Associate Director of Basic Science, UC San Diego Moores
Cancer Center, USA

Forum Agenda

Theme: “Reducing Risk: Prevention, Early Diagnosis & Innovative Treatments”

8:15am-8:45am Registration & Coffee
8:45am-8:50am Welcome and Introduction:
Victor Lopes, Let’s Talk About Mouth Cancer, UK
8:50am-8:55am Dignitary Welcome:
Catherine Calderwood, Chief Medical Officer, Scottish Government
8:55am-9:00am Special Guest Welcome:
Prof Sir David Mason.
9:00am-9:10am Presentation of GOCF Leadership Award
Awardee: To be announced at the meeting
9:10am-9:30am Keynote 1: WHO
Benoit Varenne, Dental Officer, World Health Org
9:30am-10:30am Session 1: Risk Assessment in Primary Care: Who and How?
Chair: Saman Warnakulasuriya (King’s College London & WHO CC, UK)
11:30am-11:15am Coffee Break/Poster Viewing
11:15am-12:15pm Session 2: Risk Stratification in Secondary Care: Triage and Surveillance
Chair: Ross Kerr (New York University, USA)
12:15am-1:15pm Session 3: Biomarkers for Prediction and Prognosis
Chair: Philip Sloan (Newcastle, U.K.)
1:15pm-2:15pm Lunch/Poster Viewing
Industry Sponsored Lecture: Immunobiology and Immunomodulators TBC
2:15pm-3:15pm Session 4: Risk Reduction for the Individual Patient
Chair: Victor Lopes (Let’s Talk About Mouth Cancer, UK)
3:15pm-5:30pm Global Café for Actionable Targets
Chair: Niall McGoldrick (Let’s Talk About Mouth Cancer, UK)
6.00pm-8.00pm Reception, Social Event & Networking
8:15am-9.00am Industry sponsored Breakfast Symposium- HT Bioimaging, Israel. (www.htbioimaging.com)
9:00am-10:00am Session 5: Risk and Management of Complications of Cancer Therapy
Chair: Jatin Shah (Memorial Sloan Kettering Cancer Center, USA)
10:00am-10.30am Keynote 2: Anil D’cruz (President-Elect, International Union Against Cancer, Switzerland)
10:30am-11.15am Coffee Break/Poster Viewing
11:15am-12:15pm Session 6: Frontiers of Chemoprevention, Targeted Therapy, Immunotherapy
Chair: Silvio Gutkind (Moore’s Cancer Center, USA)
12:15pm-1:30pm Session 7: Reducing Population Risk & Inequalities
Chair: Newell Johnson (Griffith University, Australia)
1:30pm-2:15pm Lunch/Poster Viewing
2:15pm-4:45pm Big Data, Artificial Intelligence, Precision Medicine…Building a Bridge to the Future: Open Global Forum
Chair: Miriam Rosin (British Columbia Cancer Agency, Canada)
4.45pm-5.30pm Present Awards and Open Session:
“What are the actionable targets of GOCF20??”

Sign Up to Stay in Informed

If you subscribe to our email list we’ll send through periodic updates on our progress with the GOCF’20 Conference.

We will not use your email address for anything else and you can unsubscribe at any time.

Newsletter Sign up